Applied Evidence
Applied Evidence
How to incorporate HIV PrEP into your practice
These recommendations and resources can help make HIV pre-exposure prophylaxis an essential part of your work.
Applied Evidence
Allergy immunotherapy: Who, what, when … and how safe?
The evidence-based answers to these and other questions will help you to update your knowledge of allergy immunotherapy.
Applied Evidence
Translating AHA/ACC cholesterol guidelines into meaningful risk reduction
The new recommendations detail refined, personalized lipid management and emphasize multiple levels of evidence. The result? Care is more complex...
Applied Evidence
A practical guide to the care of ingrown toenails
Choose either a conservative or surgical treatment approach based on severity. The Vandenbos procedure, described here, is an effective surgical...
Applied Evidence
Could that back pain be caused by ankylosing spondylitis?
It can often take years for patients with this condition to learn the true cause of their pain. But this guide to the work-up can help speed the...
Applied Evidence
High ankle sprains: Easy to miss, so follow these tips
Misdiagnosis can result in increased loss of play time and chronic ankle dysfunction. Here are the physical exam maneuvers and imaging options to...
Applied Evidence
Keeping caries at bay in breastfeeding babies
As an infant grows, human milk may become the substrate for cariogenic bacteria. Here’s what to watch for and how to counsel parents.
Applied Evidence
Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer
Patient age, baseline cardiovascular disease risk, bleeding risk, and personal preference regarding aspirin use are key to decision making. A...
Applied Evidence
It’s time to start asking all patients about intimate partner violence
Many people endure a menacing or violent romantic partner—yet few physicians ask about this risk, or actual harm. Here is a roadmap for screening...
Applied Evidence
Juvenile idiopathic arthritis: Old disease, new tactics
Beyond NSAIDs and disease-modifying antirheumatic drugs are now biologic agents and anti-interleukin drugs that can augment therapy.
Applied Evidence
To avoid Hep B reactivation, screen before immunosuppression
Universal HBV screening before immunosuppression is prudent and cost effective, even when local HBV prevalence is just 0.3%.